CROSS-REFERENCE TO RELATED APPLICATIONS
The present application is a U.S. National Stage of International Application No. PCT/EP2004/011644, filed Oct. 15, 2004, which claims priority of German Patent Application No. 103 48 044.7, filed Oct. 15, 2003.
The present invention relates to novel
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is a National Stage application of International Application No. PCT/EP2006/010818, filed on Nov. 10, 2006, which claims priority of German application number 10 2005 054 700.1, filed on Nov. 16, 2005, both of which are incorporated herein by
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to new and improved inhibitors of Dipeptidyl-Peptidase-IV (DPP-IV) with beta blocker activity, and new and improved treatment methods and related uses. The inhibitors according to the invention are useful for
This application is the U.S. national phase of International Application No. PCT/EP2014/077353 filed 11 Dec. 2014 which designated the U.S. and claims priority to EP 13196583.2 filed 11 Dec. 2013, the entire contents of each of which are hereby incorporated by reference.
BRIEF DESCRIPTION OF THE
FIELD
Described are compounds of the formula (I), their derivatives, analogs, tautomeric forms, stereoisomers, polymorphs, hydrates, solvates, intermediates, pharmaceutically acceptable salts, pharmaceutical compositions, metabolites and prodrugs thereof.
##STR00002##
Described herein is also a
BACKGROUND OF THE INVENTION
1. Field of the Invention
The invention relates to new effectors of dipeptidyl peptidase IV (DP IV) and methods of treatment comprising the topical application thereof. These effectors can be used for targeted influencing of locally limited pathophysiological and
BACKGROUND OF THE INVENTION
1. Field of the Invention
The invention relates to new effectors of dipeptidyl peptidase IV (DP IV) and methods of treatment comprising the topical application thereof. These effectors can be used for targeted influencing of locally limited pathophysiological and
FIELD OF THE INVENTION
The present invention relates to new therapeutically active and selective inhibitors of the enzyme dipeptidyl peptidase-IV (hereinafter "DPP-IV"), pharmaceutical compositions comprising the compounds and the use of such compounds for treating diseases that are associated with
The present invention relates to novel compounds including a substance named OF4949, to processes for the production thereof, to pharmaceutical compositions containing such compounds as the active agent and to methods of treatment utilizing said compounds.
More particular, the compounds of the
FIELD OF THE INVENTION
Peptide-lipid conjugates are incorporated into liposomes so as to localize delivery of the liposomes' contents to the vicinity of target cells.
BACKGROUND OF THE INVENTION
Liposomes have been widely used as carriers to deliver a variety of therapeutic and diagnostic agents
FIELD OF THE INVENTION
Peptide-lipid conjugates are incorporated into liposomes so as to localize delivery of the liposomes' contents to the vicinity of target cells.
BACKGROUND OF THE INVENTION
Liposomes have been widely used as carriers to deliver a variety of therapeutic and diagnostic agents
FIELD OF THE INVENTION
Peptide-lipid conjugates are incorporated into liposomes so as to localize delivery of the liposomes' contents to the vicinity of target cells.
BACKGROUND OF THE INVENTION
Liposomes have been widely used as carriers to deliver a variety of therapeutic and diagnostic agents
The present invention describes the combined inhibition of the activity of the enzymes Aminopeptidase N (APN; E.C. 3.4.11.2.; CD13), Dipeptidyl peptidase IV (DP IV; E.C. 3.4.14.5; CD26), Prolyl oligopeptidase (POP; Prolyl endopeptidase; PEP; E.C. 3.4.21.26), the membrane-adherent Aminopeptidase P
This application is a U.S. national stage of International Application No. PCT/JP2003/013851 filed Oct. 29, 2003.
TECHNICAL FIELD
This application relates to the invention of angiotensin-converting enzyme containing medicine. In detail, the invention of this application relates to a medicine that is
The present invention relates to a class of compounds useful in the diagnosis of sites of venous and arterial thrombosis, embolism or infection, pharmaceutical formulations containing them, their use in the diagnosis of disease and methods for their preparation.
Prior approaches to thrombus imaging
The most complete medicinal herbs database backed by science
Works in 55 languages
Herbal cures backed by science
Herbs recognition by image
Interactive GPS map - tag herbs on location (coming soon)
Read scientific publications related to your search
Search medicinal herbs by their effects
Organize your interests and stay up do date with the news research, clinical trials and patents
Type a symptom or a disease and read about herbs that might help, type a herb and see diseases and symptoms it is used against. *All information is based on published scientific research